A "dear doctor" letter was sent out to warn doctors of possible problems with Vytorin. CNBC's Mike Huckman has the details.
The word cancer being mentioned in the same breath as a cholesterol-lowering drug has investors in Merck and Schering-Plough running for the...
Well-known banking analyst Dick Bove and his firm have been sued for defamation by BankAtlantic, reports CNBC's Charlie Gasparino.
Healthcare plays, with Abhijit Chakrabortti, chief U.S. global equities strategist at Morgan Stanley
A new study identifies a potential cancer risk in certain Vytoriin patients, reports CNBC's Mike Huckman
Vytorin did not meet main goals in new study, reports CNBC's Mike Huckman
Strategies for options trading during this earning season, with Rebecca Darst, Interactive Brokers Equity and Dennis Davitt, Credit Suisse
Insight on drilling needs and America's oil crisis, with Richard McCullough, Petroleum Development Corp. president/CEO
Calfornia's attorney general is looking into new evidence of "deceptive" practices at Countrywide.
Wachovia Bank is under investigation by regulators from 10 states who demand documents on sales & marketing practices, reports CNBC's Meliss...
Daryl Guppy, CEO of Guppytraders.com charts Singapore stocks -- Wilmar International, EZRA Holdings, Cosco Corp and Golden Agri. He also cha...
Daryl Guppy, CEO of Guppytraders.com charts Australian companies -- ANZ Bank, BHP Billiton, Energy World Corp, as well as Italian energy com...
A look at the IndyMac fallout, with CNBC's Jane Wells; Paul Miller, of FBR Capital Markets; and Mike Larson, of Weiss Research
An earnings reaction and instant analysis from the company's conference call, with Steve Hoedt, National City Corp. analyst
Dividend plays, with Allan Nichols, of Morningstar, and Jeff Saut, of Raymond James
Posts |
COMPANY : Schering Plough Corp
On the Pfizer earnings conference call this morning Chairman and CEO Jeff Kindler kicked things off by calling this a "time of great uncertainty in the world economy and capital markets and significant challenges in our industry." ... Read More
22 Jul 2008
If only Merck could develop a treatment for this malady...... Read More
22 Jul 2008
Yesterday while covering the press conference about the new study on Merck and Schering-Plough's Vytorin I quoted the lead researcher, Dr... Read More
21 Jul 2008
Based on the action after hours it looks like a rough open on Tuesday... Read More
21 Jul 2008
The buyout offer from Swiss drug giant Roche has shares of DNA trading at their highest level in about two-and-a-half years and according to CNBC stock-stat maven, Robert Hum, if they close up at least 8.88% it'll be their biggest one-day percentage gain since April 15, 2005... Read More
News |
COMPANY : Schering Plough Corp
Source: The Associated Press
Source: The Associated Press
Tuesday, 22 Jul 2008
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes